New York, NY — July 17, 2018 — /D.M.O. Newswire/ — Common shares of Chemesis International Inc. have been approved for listing on the CSE.
Here’s What You Need to Know
- Chemesis International Inc. is a licensed producer and manufacturer of medical and recreational cannabis in California and Puerto Rico, currently operating a 20,000 square foot, expandable state of the art manufacturing facility in Cathedral City, California and a 120,000 square foot cultivation and manufacturing facility in Puerto Rico.
- Chemesis International Inc. seeks to be an active participant in the U.S. and international cannabis markets.
- Shares of Chemesis International Inc. will trade under the symbol ‘CSE:CSI‘.
- Trading is expected to begin on July 18th, 2018.
- There are currently 62,847,626 shares of Chemesis International Inc. issued and outstanding.
- There are 5,199,472 shares of Chemesis International Inc. reserved for issuance.
Click here for the full release.
Get Real-Time Updates from The Daily Marijuana Observer
